阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AZN 阿斯利康

交易中 07-08 14:11:01 EDT

69.95

+0.32

+0.46%

最高70.49	最低69.15	成交量279.96万
今开69.23	昨收69.63	日振幅1.92%
总市值2,169亿	流通市值2,160亿	总股本31.01亿
成交额1.96亿	换手率0.09%	流通股本30.88亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AZN","market":"US","secType":"STK","nameCN":"阿斯利康","latestPrice":69.95,"timestamp":1751998260030,"preClose":69.63,"halted":0,"volume":2799551,"delay":0,"floatShares":3088062322,"shares":3101341336,"eps":2.484749,"marketStatus":"交易中","change":0.32,"latestTime":"07-08 14:11:01 EDT","open":69.23,"high":70.485,"low":69.15,"amount":195977626.54748502,"amplitude":0.019173,"askPrice":69.95,"askSize":1000,"bidPrice":69.93,"bidSize":11,"shortable":3,"etf":0,"ttmEps":2.484749,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752004800000},"marketStatusCode":2,"adr":1,"adrRate":0.5,"listingDate":737179200000,"exchange":"NASDAQ","adjPreClose":69.63,"dividendRate":0.022159,"preHourTrading":{"tag":"盘前","latestPrice":69.25,"preClose":69.63,"latestTime":"09:29 EDT","volume":43794,"amount":3040443.99576,"timestamp":1751981397591},"postHourTrading":{"tag":"盘后","latestPrice":69.51,"preClose":69.63,"latestTime":"19:55 EDT","volume":716806,"amount":49911160.5985,"timestamp":1751932514381},"volumeRatio":0.764599,"impliedVol":0.2893,"impliedVolPercentile":0.624},"requestUrl":"/m/hq/s/AZN","defaultTab":"news","newsList":[{"id":"2549567584","title":"阿斯利康7月7日成交额为3.10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549567584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549567584?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:18","pubTimestamp":1751937528,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，阿斯利康成交额为3.10亿美元，成交额较昨日减少34.41%，当日成交量为444.17万股。阿斯利康于2025年7月7日涨0.26%，报69.63美元，该股过去5个交易日跌0.31%，年初至今涨8.0%，过去60日涨7.29%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-07|3.10亿|-34.41%|444.17万|#|2025-07-03|4.72亿|80.88%|676.80万|#|2025-07-02|2.61亿|-45.64%|367.62万|#|2025-07-01|4.80亿|85.92%|673.11万|#|2025-06-30|2.58亿|17.66%|370.17万|1999年，瑞典的Astra和英国的Zeneca集团合并成立了阿斯利康。大部分销售额来自国际市场，其中美国占其销售额的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708091851a43ccc09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708091851a43ccc09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","AZN","LU1829250122.USD","LU2236285917.USD","BK4585","LU2462157665.USD","LU2456880835.USD","BK4588","BK4007","LU2417539215.USD","BK4568","LU0889565916.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2549736539","title":"近期交易合作|阿斯利康有意购入依沃西单抗，晶泰科技与辉瑞扩大合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2549736539","media":"药菓","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549736539?lang=zh_cn&edition=full","pubTime":"2025-07-07 18:01","pubTimestamp":1751882490,"startTime":"0","endTime":"0","summary":"02晶泰科技与辉瑞深化战略合作6月30日，晶泰科技宣布与辉瑞扩大战略合作，共同开发全新一代的分子模拟平台以驱动新药研发。07腾盛博药与健康元签署抗菌新药许可协议7月4日，腾盛博药宣布已与健康元集团签署知识产权许可及技术转移协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707191358a43bbb23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707191358a43bbb23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999003800.SGD","LU1894683264.USD","LU2462157665.USD","LU0306806265.USD","BK4550","LU2417539215.USD","LU0889565916.HKD","BK4585","IE00BBT3K403.USD","LU0985481810.HKD","BK4533","IE00BLSP4239.USD","SG9999011175.SGD","BK4592","LU1066053197.SGD","PFE","SG9999001176.USD","LU0289739699.SGD","LU0225284248.USD","LU1829250122.USD","LU1057294990.SGD","BK4568","BK4599","LU0122379950.USD","SG9999013999.USD","BK4007","SG9999002232.USD","IE0002270589.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU0109394709.USD","LU0321505868.SGD","IE000M9KFDE8.USD","LU0225771236.USD","LU2236285917.USD","LU0868494617.USD","LU0306807586.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4534","LU0234572021.USD","LU0170899867.USD","LU0456855351.SGD","LU0058720904.USD","BK4581","SGXZ57979304.SGD","LU0320765992.SGD","LU1894683348.USD","AZN"],"gpt_icon":1},{"id":"2548368856","title":"三股抱团势力","url":"https://stock-news.laohu8.com/highlight/detail?id=2548368856","media":"北海茶客投研笔记","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548368856?lang=zh_cn&edition=full","pubTime":"2025-07-04 15:30","pubTimestamp":1751614217,"startTime":"0","endTime":"0","summary":"今天金融股再次发力，接力创新药。目前看来，市场上已经形成了三股抱团的势力：第一股力量是公募，公募大概率要继续抱团创新药。近期茶客研究AMC发现，这也是抱团银行股的一股重要力量，也是体制内资金：再来看从2023年以来这场体制内发起的银行股抱团运动：第三股力量是量化，量化会继续抱团微盘股。欢迎加入星球与我跟踪这三个抱团方向：","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704153108a72e44c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704153108a72e44c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU1794554557.SGD","09926","IE00BPRC5H50.USD","BK1161","BK1574","LU0348784397.USD","LU0348783233.USD","LU1720050803.USD","LU2488822045.USD","AZN","LU0417516571.SGD"],"gpt_icon":0},{"id":"2548332668","title":"【中金：维持和黄医药(00013.HK)目标价30港元 评级“跑赢行业”】智通财经APP获悉，中金发布研报称，维持和黄医","url":"https://stock-news.laohu8.com/highlight/detail?id=2548332668","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548332668?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:40","pubTimestamp":1751593232,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1989772840.SGD","LU0889565916.HKD","LU0109394709.USD","BK4162","LU1291159041.SGD","DCF","MET","BK4585","AZN","BK4588","BK1191","BK1588","LU1496350502.SGD","LU2456880835.USD","LU0320765992.SGD","HCM","LU2417539215.USD","LU2462157665.USD","LU1829250122.USD","LU1989771016.USD","BK4531","LU2236285917.USD","BK4007","LU1989772923.USD","BK1587","BK4568","00013"],"gpt_icon":0},{"id":"2548332044","title":"阿斯利康7月3日成交额为4.72亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548332044","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548332044?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:18","pubTimestamp":1751591936,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，阿斯利康成交额为4.72亿美元，成交额较昨日增加80.88%，当日成交量为676.80万股。阿斯利康于2025年7月3日跌2.36%，报69.45美元，该股过去5个交易日跌0.88%，年初至今涨7.72%，过去60日涨5.56%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-03|4.72亿|80.88%|676.80万|#|2025-07-02|2.61亿|-45.64%|367.62万|#|2025-07-01|4.80亿|85.92%|673.11万|#|2025-06-30|2.58亿|17.66%|370.17万|#|2025-06-27|2.19亿|-26.19%|313.48万|1999年，瑞典的Astra和英国的Zeneca集团合并成立了阿斯利康。大部分销售额来自国际市场，其中美国占其销售额的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704091859a4ce4d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704091859a4ce4d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","LU0109394709.USD","LU1829250122.USD","LU2456880835.USD","BK4585","AZN","BK4007","LU2236285917.USD","LU2417539215.USD","LU2462157665.USD","LU0320765992.SGD","BK4588","LU0889565916.HKD"],"gpt_icon":0},{"id":"2548331612","title":"据报Summit与阿斯利康洽谈高达150亿美元合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2548331612","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548331612?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:15","pubTimestamp":1751591743,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","BK4139","LU0320765992.SGD","LU0109394709.USD","BK4588","BK4568","LU2236285917.USD","LU1829250122.USD","AZN","BK4539","LU2417539215.USD","BK4007","LU2462157665.USD","LENZ","LU0889565916.HKD","LU2456880835.USD"],"gpt_icon":0},{"id":"2548894903","title":"艾伯维超20亿美金押注体内CAR-T细胞疗法，阿斯利康、BMS均在布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2548894903","media":"新浪医药","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548894903?lang=zh_cn&edition=full","pubTime":"2025-07-02 19:28","pubTimestamp":1751455732,"startTime":"0","endTime":"0","summary":"当地时间6月30日，制药公司艾伯维宣布，将以21亿美元的价格收购体内CAR-T细胞疗法开发商Capstan Therapeutics，以扩大自身免疫性疾病疗法的产品线。Capstan公司的抗CD19体内CAR-T细胞疗法CPTX2309已于上个月正式开始一期临床试验，用于治疗B细胞介导的自身免疫疾病。自2017年以来，美国FDA已批准了6款用于治疗B细胞恶性肿瘤的CAR-T细胞疗法。2025年3月，阿斯利康将以现金和无债务方式收购EsoBiotec，交易总额高达10亿美元，正式入驻体内CAR-T等先进细胞疗法市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702193612a4cb20f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702193612a4cb20f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4007","BK4588","LU0109394709.USD","BK4230","AZN","LU0889565916.HKD","BMS","LU2456880835.USD","BK4568","CAR","LU2462157665.USD","LU2417539215.USD","BK4022","LU2236285917.USD","BK4585","LU1829250122.USD"],"gpt_icon":0},{"id":"2548834157","title":"阿斯利康7月1日成交额为4.80亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548834157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548834157?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:18","pubTimestamp":1751419117,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，阿斯利康成交额为4.80亿美元，成交额较昨日增加85.92%，当日成交量为673.11万股。阿斯利康于2025年7月1日涨2.26%，报71.46美元，该股过去5个交易日涨1.3%，年初至今涨10.84%，过去60日跌3.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-01|4.80亿|85.92%|673.11万|#|2025-06-30|2.58亿|17.66%|370.17万|#|2025-06-27|2.19亿|-26.19%|313.48万|#|2025-06-26|2.97亿|5.76%|424.97万|#|2025-06-25|2.81亿|9.25%|402.35万|1999年，瑞典的Astra和英国的Zeneca集团合并成立了阿斯利康。大部分销售额来自国际市场，其中美国占其销售额的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702091847a4c9ede1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702091847a4c9ede1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU2236285917.USD","LU0109394709.USD","AZN","LU2456880835.USD","LU1829250122.USD","LU2417539215.USD","BK4568","BK4588","LU0889565916.HKD","LU2462157665.USD","BK4007","BK4585"],"gpt_icon":0},{"id":"2548888738","title":"阿斯利康首席执行官考虑在美股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2548888738","media":"环球市场播报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548888738?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:24","pubTimestamp":1751383459,"startTime":"0","endTime":"0","summary":"《泰晤士报》周二援引多位消息人士的话报道称，阿斯利康首席执行官帕斯卡尔・索里奥特正考虑将公司的股票上市地点迁至美国。\n　　该公司尚未立即回应路透社的置评请求。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-07-01/doc-infcytxf5210485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LU0109394709.USD","LU0320765992.SGD","LU2417539215.USD","LU2462157665.USD","LU2236285917.USD","AZN","BK4007","BK4588","BK4585","LU2456880835.USD","LU0889565916.HKD","LU1829250122.USD","BK4568"],"gpt_icon":0},{"id":"1184347923","title":"市场消息：阿斯利康CEO讨论将上市地迁往美国","url":"https://stock-news.laohu8.com/highlight/detail?id=1184347923","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184347923?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:48","pubTimestamp":1751381336,"startTime":"0","endTime":"0","summary":"已经讨论将上市地迁往美国的可能性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2e2a8110e4176e765552f0760e4fc9ef","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","AZN.UK"],"gpt_icon":0},{"id":"2548000750","title":"阿斯利康ADR涨幅迅速扩大至2.67%刷新日高，伦敦股价涨1.2%刷新日高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000750","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548000750?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:44","pubTimestamp":1751381084,"startTime":"0","endTime":"0","summary":"阿斯利康ADR涨幅迅速扩大至2.67%刷新日高，伦敦股价涨1.2%刷新日高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/01224451424848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4007","LU2462157665.USD","LU0320765992.SGD","LU1829250122.USD","LU2456880835.USD","LU0889565916.HKD","LU2236285917.USD","BK4585","LU2417539215.USD","BK4568","AZN","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"2548000438","title":"阿斯利康CEO据悉已经讨论将上市地迁往美国的可能性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000438","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548000438?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:43","pubTimestamp":1751380989,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2e2a8110e4176e765552f0760e4fc9ef","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0320765992.SGD","BK4007","BK4588","LU0109394709.USD","LU0889565916.HKD","AZN","LU2456880835.USD","BK4568","LU2462157665.USD","LU2417539215.USD","LU2236285917.USD","BK4585","LU1829250122.USD"],"gpt_icon":0},{"id":"2548000435","title":"阿斯利康ADR涨幅迅速扩大至2.67%刷新日高伦敦股价涨1.2%刷新日高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000435","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548000435?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:42","pubTimestamp":1751380921,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2456880835.USD","AZN","BK4568","LU0109394709.USD","BK4588","LU2462157665.USD","BK4007","LU0889565916.HKD","BK4585","LU0320765992.SGD","LU1829250122.USD","LU2236285917.USD","LU2417539215.USD"],"gpt_icon":0},{"id":"2548000132","title":"阿斯利康首席执行官已讨论将公司上市地点迁至美国。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000132","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548000132?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:38","pubTimestamp":1751380723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2e2a8110e4176e765552f0760e4fc9ef","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2417539215.USD","LU2456880835.USD","LU2462157665.USD","LU0320765992.SGD","BK4007","LU1829250122.USD","BK4585","LU0889565916.HKD","LU2236285917.USD","BK4588","LU0109394709.USD","AZN","BK4568"],"gpt_icon":0},{"id":"2548807361","title":"阿斯利康在北京成立全球研发公司 注册资本8000万","url":"https://stock-news.laohu8.com/highlight/detail?id=2548807361","media":"天眼查","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548807361?lang=zh_cn&edition=full","pubTime":"2025-07-01 14:55","pubTimestamp":1751352954,"startTime":"0","endTime":"0","summary":"（原标题：阿斯利康在北京成立全球研发公司 注册资本8000万）天眼查App显示，近日，阿斯利康全球研发（北京）有限公司成立，法定代表人为何静，注册资本8000万人民币，经营范围包括细胞技术研发和应用、人体基因诊断与治疗技术开发、人体干细胞技术开发和应用等。股东信息显示，该公司由阿斯利康大陆有限公司全资持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507011514539795915e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507011514539795915e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4588","BK4585","LU1829250122.USD","BK4007","LU0889565916.HKD","LU2456880835.USD","LU2236285917.USD","LU2462157665.USD","LU2417539215.USD","BK4568","LU0109394709.USD","AZN"],"gpt_icon":0},{"id":"2548568029","title":"9款重磅疗法上市！2025上半年获批肺癌新药全盘点","url":"https://stock-news.laohu8.com/highlight/detail?id=2548568029","media":"药时代","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548568029?lang=zh_cn&edition=full","pubTime":"2025-07-01 12:44","pubTimestamp":1751345064,"startTime":"0","endTime":"0","summary":"恒瑞与百济神州HER2靶向新药获批上市MNC与本土创新药企正面交锋ADC与双抗成研发焦点2025年上半年的新药获批潮，彻底改变了肺癌治疗领域的产业竞争格局。从\"精准治疗\"到\"治愈可能\"研发管线勾勒下一个突破点2025年上半年的9款新药上市，只是肺癌治疗革命的序幕。结 语站在2025年中节点回望，肺癌治疗领域的突破速度令人惊叹。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701124740a4c8199d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701124740a4c8199d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU2456880835.USD","BK4588","LU0889565916.HKD","LU2462157665.USD","BK4585","LU2236285917.USD","LU0320765992.SGD","LU1829250122.USD","BK4568","LU0109394709.USD","LU2417539215.USD","AZN"],"gpt_icon":0},{"id":"2548216042","title":"阿斯利康6月30日成交额为2.58亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548216042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548216042?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:18","pubTimestamp":1751332698,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，阿斯利康成交额为2.58亿美元，成交额较昨日增加17.66%，当日成交量为370.17万股。阿斯利康于2025年6月30日涨0.04%，报69.88美元，该股过去5个交易日跌1.08%，年初至今涨8.39%，过去60日跌3.24%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-30|2.58亿|17.66%|370.17万|#|2025-06-27|2.19亿|-26.19%|313.48万|#|2025-06-26|2.97亿|5.76%|424.97万|#|2025-06-25|2.81亿|9.25%|402.35万|#|2025-06-24|2.57亿|23.88%|364.68万|1999年，瑞典的Astra和英国的Zeneca集团合并成立了阿斯利康。大部分销售额来自国际市场，其中美国占其销售额的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701091825a7272a9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701091825a7272a9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0320765992.SGD","LU0109394709.USD","BK4588","BK4568","LU2236285917.USD","LU1829250122.USD","AZN","LU2417539215.USD","BK4007","LU2462157665.USD","LU0889565916.HKD","LU2456880835.USD"],"gpt_icon":0},{"id":"2547906638","title":"【和黄医药(00013.HK)宣布沃瑞沙®和泰瑞沙®的联合疗法于中国获批用于治疗伴有MET扩增的一线 EGFR抑制剂治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2547906638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547906638?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:45","pubTimestamp":1751273124,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0109394709.USD","BK4007","LU0320765992.SGD","LU2456880835.USD","LU2236285917.USD","BK1588","LU1989772923.USD","LU1989772840.SGD","MET","LU1496350502.SGD","BK4531","AZN","BK4588","BK1587","00013","LU1829250122.USD","BK4568","LU2462157665.USD","BK1191","BK4162","BK4585","LU1291159041.SGD","LU2417539215.USD","LU1989771016.USD","HCM","LU0889565916.HKD"],"gpt_icon":0},{"id":"2547303084","title":"五年后，谁将是全球最畅销的药？","url":"https://stock-news.laohu8.com/highlight/detail?id=2547303084","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547303084?lang=zh_cn&edition=full","pubTime":"2025-06-30 10:47","pubTimestamp":1751251653,"startTime":"0","endTime":"0","summary":"2030年全球最畅销药物排行榜到2030年，受糖尿病与肥胖症药物持续热销的推动，礼来将跃居全球处方药销售榜首，其处方药年销售额预计将达到1126亿美元，遥遥领先于排名第二、销售额预计为839亿美元的诺和诺德。诺和诺德的Cagrisema高居榜首，净现值高达800亿美元，2030年全球销售额预计将达152亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630105229a4c57c44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630105229a4c57c44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823416689.USD","LU1868836914.USD","LU1929549753.HKD","LU2602419157.SGD","SG9999017495.SGD","LU1941712264.USD","LU0689472784.USD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU0198837287.USD","BK4007","LU2552382132.HKD","LU1116320901.HKD","SGXZ31699556.SGD","SGXZ57979304.SGD","LU2063271972.USD","LU1720051108.HKD","SG9999014559.SGD","LU1430594728.SGD","LU2211815571.USD","LU1061106388.HKD","LU1162221912.USD","LU1804176565.USD","LU0265550946.USD","BK4533","LU0097036916.USD","NPV","BK4599","SG9999014914.USD","LU2491050071.SGD","AZN","IE00BKVL7J92.USD","SG9999001440.SGD","IE00BZ1G4Q59.USD","LU0096364046.USD","LU2264538146.SGD","LLY","LU2456880835.USD","SG9999002232.USD","IE00BJLML261.HKD","LU2361045086.USD","LU0203202063.USD","LU0006306889.USD","NVO","SGXZ51526630.SGD","MRK","LU0861579265.USD","IE00BK4W5L77.USD","IE00BJT1NW94.SGD","LU0238689110.USD","SG9999013999.USD"],"gpt_icon":1},{"id":"2546778839","title":"阿斯利康6月27日成交额为2.19亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546778839","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546778839?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:18","pubTimestamp":1751073505,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，阿斯利康成交额为2.19亿美元，成交额较昨日减少26.19%，当日成交量为313.48万股。阿斯利康于2025年6月27日跌0.31%，报69.85美元，该股过去5个交易日跌0.14%，年初至今涨8.34%，过去60日跌3.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-27|2.19亿|-26.19%|313.48万|#|2025-06-26|2.97亿|5.76%|424.97万|#|2025-06-25|2.81亿|9.25%|402.35万|#|2025-06-24|2.57亿|23.88%|364.68万|#|2025-06-23|2.08亿|-52.98%|294.98万|1999年，瑞典的Astra和英国的Zeneca集团合并成立了阿斯利康。大部分销售额来自国际市场，其中美国占其销售额的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628091834a721d5bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628091834a721d5bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AZN","LU2417539215.USD","LU0109394709.USD","LU0889565916.HKD","LU2456880835.USD","BK4568","BK4588","BK4007","LU2236285917.USD","LU1829250122.USD","LU2462157665.USD","LU0320765992.SGD","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.astrazeneca.com","stockEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0446},{"period":"3month","weight":0.0729},{"period":"6month","weight":0.0458},{"period":"1year","weight":-0.0997},{"period":"ytd","weight":0.0627}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.036},{"period":"3month","weight":0.2502},{"period":"6month","weight":0.0529},{"period":"1year","weight":0.1191},{"period":"ytd","weight":0.059}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"阿斯利康股份有限公司于1992年6月17日根据1985年《公司法》在英格兰和威尔士注册成立。该公司是在1993年将Imperial化学工业公司的制药、农化和特种化学品业务分拆时成立的。1999年，公司出售了特种化学品业务。同样在1999年，该公司与瑞典Astra公司合并。2000年，该公司将农化业务分拆，并将其与诺华公司的同类业务合并，成立了一家新的公司Syngenta AG。2007年，集团收购了位于美国的生物制剂和疫苗企业MedImmune。2021年，集团收购了位于美国的罕见病企业Alexion。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.001428},{"month":2,"riseRate":0.40625,"avgChangeRate":-0.017129},{"month":3,"riseRate":0.5625,"avgChangeRate":0.027992},{"month":4,"riseRate":0.65625,"avgChangeRate":0.031251},{"month":5,"riseRate":0.53125,"avgChangeRate":0.008752},{"month":6,"riseRate":0.454545,"avgChangeRate":0.018335},{"month":7,"riseRate":0.575758,"avgChangeRate":-0.004014},{"month":8,"riseRate":0.46875,"avgChangeRate":0.002026},{"month":9,"riseRate":0.5625,"avgChangeRate":0.002514},{"month":10,"riseRate":0.53125,"avgChangeRate":0.013465},{"month":11,"riseRate":0.5,"avgChangeRate":-0.000033},{"month":12,"riseRate":0.5625,"avgChangeRate":0.007964}],"exchange":"NASDAQ","name":"阿斯利康","nameEN":"AstraZeneca PLC"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.2","shortVersion":"4.34.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阿斯利康(AZN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阿斯利康,AZN,阿斯利康股票,阿斯利康股票老虎,阿斯利康股票老虎国际,阿斯利康行情,阿斯利康股票行情,阿斯利康股价,阿斯利康股市,阿斯利康股票价格,阿斯利康股票交易,阿斯利康股票购买,阿斯利康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阿斯利康(AZN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阿斯利康(AZN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}